September 5th, 2025: Research Suggests GLP-1 Medications May Raise Kidney Cancer Risk Amid Growing Litigation A new study published in JAMA Oncology suggests that GLP-1 receptor agonists such as Ozempic and Mounjaro could increase the risk of kidney cancer, despite appearing to lower the risk of certain other cancers
Regulatory and pro-inflammatory cytokines in Brazilian living-related renal transplant recipients according to creatinine plasma levels
Also known as GLP-1 agonists, GLP-1s help regulate blood sugar levels and were originally developed to treat type 2 diabetes
Meet the Experts True, these benefits sound similar to those of retinol, but tretinoin differs in that the ingredient is in its most potent, active form right out of the tube
Metabolic and Lipolytic Signaling Pathways Beyond anabolic signaling, IGF-1 LR3s receptor activation is linked to metabolic effects documented in research settings, including increased glucose uptake into muscle and adipose tissue via GLUT-4 transporter upregulation and enhanced amino acid transport that supports tissue repair processes
